Okami Medical ALPHA Registry

Enrolling by invitation

Conditions studied: Arterial Bleed, Pulmonary Arteriovenous Malformation, Embolization, Hemorrhage

In brief

This registry will provide insights into the use of Okami Medical devices in real-world clinical and study effectiveness and safety of Okami Medical devices.

Key facts

Study ID

NCT07525518

Run by

Okami Medical, Inc.

People needed

500

Starts

2026-03-31

Expected to finish

2030-08-01

Last updated by the study team

2026-07-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The patient or their legally authorized representative is willing and able to provide informed consent per local requirements
• Has or will receive treatment with an eligible Okami Medical device
• Age ≥ 18 years

You may not qualify if…

• Is or will be inaccessible for registry follow-up
• Meets exclusion criteria required by local requirements
• Current or planned participation in a drug or device study that would interfere with participation in this registry or confound the results of this registry in the opinion of the investigator

Where it is running

• University of Colorado — Aurora, Colorado, United States
• UMASS Chan Medical School — Worcester, Massachusetts, United States
• University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States
• Charlotte Radiology — Charlotte, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.